ISOFOL — Isofol Medical AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00
- SEK111.45m
- -SEK17.05m
- SEK0.72m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 127 | 116 | 379 | 191 | 138 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.66 | 11.1 | 12.3 | 18.2 | 2.15 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 137 | 140 | 395 | 210 | 141 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.43 | 3.26 | 1.75 | 0.091 | 0.003 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 146 | 148 | 401 | 210 | 141 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 38.8 | 80.1 | 83 | 50.5 | 18.3 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 41.6 | 81.6 | 83.1 | 51.4 | 19.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 105 | 66.6 | 318 | 159 | 121 |
Total Liabilities & Shareholders' Equity | 146 | 148 | 401 | 210 | 141 |
Total Common Shares Outstanding |